Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1225154

	registered interest
	date	15/07/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Multiple Sclerosis: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he plans to take to implement the recommendations of the report, The Forgotten Many: A 2020 Vision for Secondary Progressive Multiple Sclerosis, published in June 2020.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	74474
	answer	answer is ministerial correction date of answer 04/08/2020 answer text <p>‘The Forgotten Many: A 2020 Vision for Secondary Progressive Multiple Sclerosis’, was published in June 2020 and was funded by Novartis.</p><p>The report sets out a wide range of recommendations for NHS England and NHS Improvement and local commissioners around awareness, treatment pathways and support. NHS England and NHS Improvement are aware of the report, and a range of activity is underway to improve awareness, treatment, care and support for people neurological conditions, including secondary progressive multiple sclerosis (SPMS), which are relevant to the recommendations.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 04/08/2020 13:59:50 answering member 4527 label Biography information for Helen Whately previous answer version 38834 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
	tabling member	1538 label Biography information for Rosie Cooper

1225152

	registered interest
	date	15/07/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Multiple Sclerosis: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what support his Department is providing to local NHS services to improve the care of people with secondary progressive multiple sclerosis.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	74472
	answer	answer is ministerial correction date of answer 23/07/2020 answer text <p>In order to improve the care and outcomes for people with progressive neurological conditions, such as secondary progressive multiple sclerosis (MS), NHS England and NHS Improvement produced a progressive neurological conditions RightCare toolkit, in collaboration with key stakeholders such as the MS Trust and the MS Society. This toolkit supports systems to understand the priorities in care for people living with various progressive neurological conditions, in line with best practice guidelines.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) guideline ‘Multiple sclerosis in adults: management’, updated in 2019 sets out best practice on the diagnosis, treatment, care and support of people MS. On secondary progressive MS, the guidance sets out that “While a variety of symptomatic treatments is available, progression in secondary progressive MS is currently intractable, and immunomodulatory strategies used for relapse remitting MS have not proven effective when extended into secondary progressive MS.”</p><p> </p><p> </p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 74473 question first answered 23/07/2020 11:44:05 answering member 4527 label Biography information for Helen Whately
	tabling member	1538 label Biography information for Rosie Cooper

1225153

	registered interest
	date	15/07/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Multiple Sclerosis: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve outcomes for people living with secondary progressive multiple sclerosis.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	74473
	answer	answer is ministerial correction date of answer 23/07/2020 answer text <p>In order to improve the care and outcomes for people with progressive neurological conditions, such as secondary progressive multiple sclerosis (MS), NHS England and NHS Improvement produced a progressive neurological conditions RightCare toolkit, in collaboration with key stakeholders such as the MS Trust and the MS Society. This toolkit supports systems to understand the priorities in care for people living with various progressive neurological conditions, in line with best practice guidelines.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) guideline ‘Multiple sclerosis in adults: management’, updated in 2019 sets out best practice on the diagnosis, treatment, care and support of people MS. On secondary progressive MS, the guidance sets out that “While a variety of symptomatic treatments is available, progression in secondary progressive MS is currently intractable, and immunomodulatory strategies used for relapse remitting MS have not proven effective when extended into secondary progressive MS.”</p><p> </p><p> </p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 74472 question first answered 23/07/2020 11:44:05 answering member 4527 label Biography information for Helen Whately
	tabling member	1538 label Biography information for Rosie Cooper